ATOH8’s inhibitory effect on cell migration and invasion contrasts with DNASE2’s promotion of these cellular processes, suggesting that their distinct roles could be leveraged in developing targeted therapies to modulate breast cancer progression. Here, ATOH8 is linked to breast carcinoma.